newsfilter
← Latest News
GlobeNewswire·

iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates

– Preparation underway with GSK for Phase 3 registrational studies evaluating belrestotug and dostarlimab combination – Initiated enrollment in Phase 1 trial of EOS-984, a first-in-class program targeting a new